Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.6B |
| FY2017, ended Dec 31, 2017 | $35.9B |
| FY2018, ended Dec 31, 2018 | $28.5B |
| FY2019, ended Dec 31, 2019 | $49.9B |
| FY2020, ended Dec 31, 2020 | $63.8B |
| FY2021, ended Dec 31, 2021 | $76.7B |
| FY2022, ended Dec 31, 2022 | $60.8B |
| FY2023, ended Dec 31, 2023 | $76.2B |
| FY2024, ended Dec 31, 2024 | $91.8B |
| FY2025, ended Dec 31, 2025 | $75.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $103B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $3.61B |
| FY2017, ended Dec 31, 2017 | $4.37B |
| FY2018, ended Dec 31, 2018 | $5.07B |
| FY2019, ended Dec 31, 2019 | $5.56B |
| FY2020, ended Dec 31, 2020 | $6.00B |
| FY2021, ended Dec 31, 2021 | $6.64B |
| FY2022, ended Dec 31, 2022 | $7.26B |
| FY2023, ended Dec 31, 2023 | $8.19B |
| FY2024, ended Dec 31, 2024 | $8.75B |
| FY2025, ended Dec 31, 2025 | $9.22B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $9.80B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $127M | −$94.0M |
| FY2017, ended Dec 31, 2017 | $233M | $60.5M |
| FY2018, ended Dec 31, 2018 | $365M | −$281M |
| FY2019, ended Dec 31, 2019 | $507M | −$86.8M |
| FY2020, ended Dec 31, 2020 | $370M | $27.3M |
| FY2021, ended Dec 31, 2021 | $500M | −$204M |
| FY2022, ended Dec 31, 2022 | $705M | $685M |
| FY2023, ended Dec 31, 2023 | $969M | $436M |
| FY2024, ended Dec 31, 2024 | $815M | $183M |
| FY2025, ended Dec 31, 2025 | $1.35B | −$400M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.53B | −$1.46B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $748M |
| FY2017, ended Dec 31, 2017 | $1.41B |
| FY2018, ended Dec 31, 2018 | $606M |
| FY2019, ended Dec 31, 2019 | $1.87B |
| FY2020, ended Dec 31, 2020 | $1.60B |
| FY2021, ended Dec 31, 2021 | $1.54B |
| FY2022, ended Dec 31, 2022 | $1.91B |
| FY2023, ended Dec 31, 2023 | $2.10B |
| FY2024, ended Dec 31, 2024 | $3.08B |
| FY2025, ended Dec 31, 2025 | $1.73B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $979M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.31B |
| FY2017, ended Dec 31, 2017 | $8.47B |
| FY2018, ended Dec 31, 2018 | $9.89B |
| FY2019, ended Dec 31, 2019 | $10.4B |
| FY2020, ended Dec 31, 2020 | $10.6B |
| FY2021, ended Dec 31, 2021 | $11.7B |
| FY2022, ended Dec 31, 2022 | $12.9B |
| FY2023, ended Dec 31, 2023 | $13.8B |
| FY2024, ended Dec 31, 2024 | $15.3B |
| FY2025, ended Dec 31, 2025 | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $19.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 37.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 71.6M |
| FY2017, ended Dec 31, 2017 | 79.2M |
| FY2018, ended Dec 31, 2018 | 80.9M |
| FY2019, ended Dec 31, 2019 | 85.4M |
| FY2020, ended Dec 31, 2020 | 89.3M |
| FY2021, ended Dec 31, 2021 | 90.7M |
| FY2022, ended Dec 31, 2022 | 92.7M |
| FY2023, ended Dec 31, 2023 | 94.6M |
| FY2024, ended Dec 31, 2024 | 97.3M |
| FY2025, ended Dec 31, 2025 | 98.3M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 98.7M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $156M | $0 | $2.08B |
| FY2017, ended Dec 31, 2017 | — | $176M | $2.48B | — |
| FY2018, ended Dec 31, 2018 | — | $181M | $388M | — |
| FY2019, ended Dec 31, 2019 | — | $237M | $1.66B | — |
| FY2020, ended Dec 31, 2020 | — | $295M | $1.98B | — |
| FY2021, ended Dec 31, 2021 | — | $364M | $498M | — |
| FY2022, ended Dec 31, 2022 | — | $404M | $796M | — |
| FY2023, ended Dec 31, 2023 | — | $407M | $734M | — |
| FY2024, ended Dec 31, 2024 | — | $462M | $1.67B | — |
| FY2025, ended Dec 31, 2025 | — | $498M | $99.0M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — | $531M | $0 | — |
Valuation
At current price- Market Cap
- $98.6B
- P/E
- 64.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 10.1×
- Price / Book
- 6.9×
- EV / EBITDA
- 27.3×
Growth
Trailing 12 months- Revenue (TTM)
- $9.80B
- Revenue Growth YoY
- 9.6%
- Revenue CAGR 3Y
- 8.3%
- Revenue CAGR 5Y
- 9.0%
- EPS Growth YoY
- 52.8%
- Net Income Growth YoY
- 54.2%
Profitability
Trailing 12 months- Gross Margin
- 51.5%
- Operating Margin
- 21.8%
- Net Margin
- 15.6%
- FCF Margin
- −14.9%
- Return on Equity
- 10.8%
Earnings
Trailing 12 months- Net Income
- $1.53B
- EPS (diluted)
- $15.54
- EBITDA
- $4.30B
- Operating Income
- $2.14B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $979M
- Total Debt
- $19.9B
- Net Debt
- $18.9B
- Total Assets
- $41.1B
- Total Liabilities
- $26.7B
- Shareholders' Equity
- $14.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.94B
- Capital Expenditure
- $5.41B
- Free Cash Flow
- −$1.46B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $20.17
- Beta (5Y)
- 0.98
Every ratio is calculated from the company’s reported figures.